Insulin Aspart
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01306 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 17 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | type 1 diabetes mellitus | KG + DL |
| 2 | autoimmune oophoritis | KG + DL |
| 3 | opsismodysplasia | KG + DL |
| 4 | thiamine-responsive dysfunction syndrome | KG + DL |
| 5 | permanent neonatal diabetes mellitus | KG + DL |
| 6 | focal stiff limb syndrome | KG + DL |
| 7 | classic stiff person syndrome | KG + DL |
| 8 | pancreatic agenesis | KG + DL |
| 9 | drug-induced localized lipodystrophy | KG + DL |
| 10 | centrifugal lipodystrophy | KG + DL |
| 11 | pressure-induced localized lipoatrophy | KG + DL |
| 12 | idiopathic localized lipodystrophy | KG + DL |
| 13 | IDDM 1 | KG + DL |
| 14 | glaucoma | KG + DL |
| 15 | diabetes mellitus, insulin-dependent, X-linked, susceptibility to | KG + DL |
| 16 | esophageal varices with bleeding | KG + DL |
| 17 | esophageal varices without bleeding | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.